HSPA5 and neoplasm: We demonstrated using molecular docking and molecular dynamics simulations that GRP78 binds to Kringle 5 and triggers the death of tumor cells, indicating that it may be beneficial as a therapeutic agent to site-direct and localize cancer cells.